4.8 Article

Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient mice

期刊

EMBO JOURNAL
卷 26, 期 15, 页码 3686-3698

出版社

WILEY
DOI: 10.1038/sj.emboj.7601803

关键词

hyperplasia; peroxisome proliferator-activated receptor beta/delta; p57(KIP2)/Cdkn1c; tumor angiogenesis; tumor growth

资金

  1. NCI NIH HHS [R01 CA124533, CA97999, R01 CA097999, R01 CA089607, CA89607, CA124533] Funding Source: Medline

向作者/读者索取更多资源

The peroxisome proliferator-activated receptor-beta (PPAR beta) has been implicated in tumorigenesis, but its precise role remains unclear. Here, we show that the growth of syngeneic Pparb wild-type tumors is impaired in Pparb(-/-) mice, concomitant with a diminished blood flow and an abundance of hyperplastic microvascular structures. Matrigel plugs containing pro-angiogenic growth factors harbor increased numbers of morphologically immature, proliferating endothelial cells in Pparb(-/-) mice, and retroviral transduction of Pparb triggers microvessel maturation. We have identified the Cdkn1c gene encoding the cell cycle inhibitor p57(Kip2) as a PPARb target gene and a mediator of the PPAR beta-mediated inhibition of cell proliferation, which provides a possible mechanistic explanation for the observed tumor endothelial hyperplasia and deregulation of tumor angiogenesis in Pparb(-/-) mice. Our data point to an unexpected essential role for PPARb in constraining tumor endothelial cell proliferation to allow for the formation of functional tumor microvessels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据